JP2010512333A5 - - Google Patents

Download PDF

Info

Publication number
JP2010512333A5
JP2010512333A5 JP2009540418A JP2009540418A JP2010512333A5 JP 2010512333 A5 JP2010512333 A5 JP 2010512333A5 JP 2009540418 A JP2009540418 A JP 2009540418A JP 2009540418 A JP2009540418 A JP 2009540418A JP 2010512333 A5 JP2010512333 A5 JP 2010512333A5
Authority
JP
Japan
Prior art keywords
type
palonosetron hydrochloride
composition
melting point
palonosetron
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009540418A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010512333A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/086350 external-priority patent/WO2008073757A1/en
Publication of JP2010512333A publication Critical patent/JP2010512333A/ja
Publication of JP2010512333A5 publication Critical patent/JP2010512333A5/ja
Pending legal-status Critical Current

Links

JP2009540418A 2006-12-07 2007-12-04 塩酸パロノセトロンの結晶及び非晶質形 Pending JP2010512333A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87365606P 2006-12-07 2006-12-07
PCT/US2007/086350 WO2008073757A1 (en) 2006-12-07 2007-12-04 Crystalline and amorphous forms of palonosetron hydrochloride

Publications (2)

Publication Number Publication Date
JP2010512333A JP2010512333A (ja) 2010-04-22
JP2010512333A5 true JP2010512333A5 (enExample) 2010-11-11

Family

ID=39512092

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009540418A Pending JP2010512333A (ja) 2006-12-07 2007-12-04 塩酸パロノセトロンの結晶及び非晶質形

Country Status (4)

Country Link
US (4) US20100105724A1 (enExample)
EP (1) EP2099298A4 (enExample)
JP (1) JP2010512333A (enExample)
WO (1) WO2008073757A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8614225B2 (en) 2006-08-30 2013-12-24 Dr. Reddy's Laboratories Limited Process for the purification of palonosetron or its salt
HRPK20100281B3 (hr) 2006-10-23 2012-01-31 Sicor Inc. Kristalni oblici palonosetron hidroklorida
JP2010512333A (ja) * 2006-12-07 2010-04-22 ヘルシン ヘルスケア ソシエテ アノニム 塩酸パロノセトロンの結晶及び非晶質形
WO2009087643A1 (en) * 2008-01-11 2009-07-16 Natco Pharma Limited Novel crystalline forms of palonosetron hydrochloride
EP2364312A4 (en) * 2008-11-11 2012-05-02 Reddys Lab Ltd Dr SYNTHESIS OF CRYSTALLINE PALONOSETRON CHLORHYDRATE
EP2448936A2 (en) 2009-06-30 2012-05-09 Ranbaxy Laboratories Limited Processes for the preparation of form i and form ii of palonosetron hydrochloride
WO2011115069A1 (ja) * 2010-03-19 2011-09-22 第一三共株式会社 結晶の網羅的探索
CN114315821A (zh) * 2021-12-23 2022-04-12 北大医药股份有限公司 一种盐酸帕洛诺司琼无定形晶型的制备方法
EP4385497A1 (en) 2022-12-12 2024-06-19 Alfred E. Tiefenbacher (GmbH & Co. KG) Antioxidant-free fixed dose combination of netupitant and palonosetron
WO2024126408A1 (en) 2022-12-12 2024-06-20 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Antioxidant-free fixed dose combination of netupitant and palonosetron
EP4385500A1 (en) 2022-12-12 2024-06-19 Alfred E. Tiefenbacher (GmbH & Co. KG) Fixed dose combination comprising netupitant and palonosetron
KR20250125376A (ko) 2022-12-12 2025-08-21 알프레드 이. 티펜바흐어 게엠베하 운트 ＆ 코. 카게 네투피탄트 및 팔로노세트론을 포함하는 고정 용량 복합제

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ236225A (en) * 1989-11-28 1992-09-25 Syntex Inc Azabicyclic-substituted isoquinoline derivatives, intermediates and pharmaceutical compositions
US5567818A (en) * 1994-07-08 1996-10-22 Syntex (U.S.A.) Inc. Processes for preparing 2-(1-azabicyclo[2.2.2]oct-3-yl)-1H-benz[de] isoquinolin-1-one derivatives and intermediates useful therein
US5510486A (en) * 1994-07-26 1996-04-23 Syntex (U.S.A.) Inc. Process for preparing 2-(1-azabicyclo 2.2.2!oct-3-yl)-2,3,3A,4,5,6-hexahydro-1H-benz de!isoquinolin-1-one
GB9713730D0 (en) * 1997-06-30 1997-09-03 Ciba Geigy Ag Organic compounds
JP3566105B2 (ja) * 1998-09-14 2004-09-15 財団法人化学技術戦略推進機構 含ヘテロ芳香環スルホニウム塩及び熱硬化性組成物
DE19956786A1 (de) * 1999-11-25 2001-05-31 Basf Ag Verfahren zur Herstellung optisch aktiver Amine
ES2204358T1 (es) * 2000-10-30 2004-05-01 Teva Pharmaceutical Industries Ltd. Nuevas formas de cristal y de disolvente de hidrocloruro de ondasetron y procedimientos para su preparacion.
US7766013B2 (en) * 2001-06-05 2010-08-03 Alexza Pharmaceuticals, Inc. Aerosol generating method and device
US7064139B2 (en) * 2001-10-29 2006-06-20 Uniroyal Chemical Company, Inc. Method for treating retroviral infections
US20050131045A1 (en) * 2002-04-30 2005-06-16 Judith Aronhime Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical, compositions containing the novel forms and methods for treating nausea using them
JP5690461B2 (ja) * 2002-11-15 2015-03-25 ヘルシン ヘルスケア ソシエテ アノニム 化学療法誘導嘔吐を治療するためのパロノセトロン
CN1768750A (zh) * 2004-11-07 2006-05-10 重庆医药工业研究院有限责任公司 帕洛诺司琼冻干制剂及其制备方法
HRPK20100281B3 (hr) * 2006-10-23 2012-01-31 Sicor Inc. Kristalni oblici palonosetron hidroklorida
JP2010512333A (ja) * 2006-12-07 2010-04-22 ヘルシン ヘルスケア ソシエテ アノニム 塩酸パロノセトロンの結晶及び非晶質形

Similar Documents

Publication Publication Date Title
WO2009102155A3 (en) Process for preparation of 2-methyl-2´-phenylpropionic acid derivatives and novel intermediate compounds
JP2009235100A5 (enExample)
JP2012501649A5 (enExample)
JP2004161992A5 (enExample)
NZ602450A (en) Agomelatine hydrochloride hydrate and preparation thereof
NZ597210A (en) Rebaudioside a composition and method for purifying rebaudioside a
JP2012528877A5 (enExample)
WO2010033444A8 (en) Crystalline forms of a 2-thiazolyl- 4-quinolinyl-oxy derivative, a potent hcv inhibitor
JP2012132799A5 (enExample)
WO2010104344A3 (en) Process for preparing prostaglandin derivatives
WO2008058236A3 (en) Methods for preparing cinacalcet hydrochloride
WO2010004197A3 (fr) Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique
WO2008140641A3 (en) Pure paliperidone and processes for preparing thereof
JP2007532560A5 (enExample)
JP2009179634A5 (enExample)
WO2014196827A3 (en) Novel amino-silyl amine compound, method for perparing the 'same and silicon-containing thin-film using the same
WO2009033900A3 (de) Verfahren zum reinigen von polykristallinem silicium
EA201300647A1 (ru) Оптимизированный синтез чистых неполиморфных кристаллических жёлчных кислот с заданным размером частиц
WO2009122303A3 (en) Novel mandelate salt of fesoterodine
RU2009119567A (ru) Уменьшение избыточной массы тела или ожирения
AR081267A1 (es) Procedimiento de obtencion de la forma cristalina a del febuxostat
JP2008514558A5 (enExample)
NO20073440L (no) Prosess for fremstilling av candesartan
WO2011077309A3 (en) Vaccine compositions
WO2010003942A3 (en) Preparation of duloxetine and its pharmaceutically acceptable salts by the use of asymmetric transfer hydrogenation process